/ EN
2025-11-25 00:00 United States Policy & Regulation Regulatory Approval Translated from EN

FDA Clears Naox NX01 Reduced-Montage EEG Device

Summary The FDA cleared Naox Technologies' NX01 on November 25, 2025, finding it substantially equivalent under submission number K251550 through the traditional 510(k) pathway. The agency classifies it as a Reduced-Montage Standard Electroencephalograph, a Class II device under regulation 882.1400, with neurology as the assigned review panel. Reduced-montage systems record with fewer electrodes than a conventional clinical montage, trading spatial resolution for faster setup and the possibility of wearable form factors.
Why it matters Reduced-montage EEG is the design point where clinical-grade recording and wearable hardware converge, and clearance is what separates a device a neurologist can act on from a consumer headband.

BCIwiki (bciwiki.com) — Naox Technologies Sas received an FDA 510(k) decision of Substantially Equivalent for NX01 (NX01) on November 25, 2025, under submission number K251550. The submission followed the Traditional 510(k) clearance pathway.

FDA lists the product under the device classification name Reduced- Montage Standard Electroencephalograph. It is a Class 2 device under regulation number 882.1400, assigned to the Neurology advisory committee. Reduced-montage systems record with fewer electrodes than a conventional clinical montage, trading spatial resolution for faster setup and the possibility of wearable form factors.

Compiled by BCIwiki from public sources

Sources · 1
Read original ↗
Suggest a correction Revisions · none / EN
© 2026 BCIwiki.com Digest Topics Tips Subscribe Revisions About